tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NVCR Stock Latest News

Novocure to present results of METIS phase 3 trial at ASCO 2024
The FlyNovocure to present results of METIS phase 3 trial at ASCO 2024
1d ago
NVCR
Novocure price target raised to $28 from $25 at Piper Sandler
PremiumThe Fly
Novocure price target raised to $28 from $25 at Piper Sandler
16d ago
NVCR
Novocure announces 20 presentations at AACR 2024
PremiumThe Fly
Novocure announces 20 presentations at AACR 2024
21d ago
NVCR
Novocure price target lowered to $42 from $49 at Wells Fargo
PremiumThe Fly
Novocure price target lowered to $42 from $49 at Wells Fargo
23d ago
NVCR
Novocure METIS results ‘not a home run,’ says H.C. Wainwright
PremiumThe Fly
Novocure METIS results ‘not a home run,’ says H.C. Wainwright
29d ago
NVCR
NovoCure trading resumes
PremiumThe FlyNovoCure trading resumes
29d ago
NVCR
NovoCure trading halted, volatility trading pause
PremiumThe Fly
NovoCure trading halted, volatility trading pause
29d ago
NVCR
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
PremiumThe Fly
Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint
29d ago
NVCR
ZLAB
Novocure spikes 30% after drug trial met primary endpoint
PremiumThe Fly
Novocure spikes 30% after drug trial met primary endpoint
29d ago
NVCR
NovoCure’s METIS Trial Shows Promise in Brain Cancer Treatment
PremiumCompany Announcements
NovoCure’s METIS Trial Shows Promise in Brain Cancer Treatment
30d ago
8K
NVCR
Novocure: METIS Phase 3 clinical trial met primary endpoint in NSCLC study
PremiumThe Fly
Novocure: METIS Phase 3 clinical trial met primary endpoint in NSCLC study
30d ago
NVCR
Novocure price target raised to $22 from $21 at H.C. Wainwright
PremiumThe Fly
Novocure price target raised to $22 from $21 at H.C. Wainwright
2M ago
NVCR
NovoCure trading resumes
PremiumThe FlyNovoCure trading resumes
2M ago
NVCR
NovoCure trading halted, volatility trading pause
PremiumThe Fly
NovoCure trading halted, volatility trading pause
2M ago
NVCR
Novocure reports Q4 EPS (45c), consensus (52c)
PremiumThe Fly
Novocure reports Q4 EPS (45c), consensus (52c)
2M ago
NVCR
NVCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NVCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
NVCR
NovoCure’s Lung Cancer Therapy Application Accepted by FDA
PremiumMarket News
NovoCure’s Lung Cancer Therapy Application Accepted by FDA
3M ago
8K
NVCR
FDA accepts Novocure PMA application for TTFields therapy in NSCLC
PremiumThe Fly
FDA accepts Novocure PMA application for TTFields therapy in NSCLC
3M ago
NVCR
Novocure enrolls final patient in TRIDENT clinical trial
PremiumThe Fly
Novocure enrolls final patient in TRIDENT clinical trial
4M ago
NVCR
Novocure sees FY23 revenue $509.3M, consensus $505.05M
PremiumThe FlyNovocure sees FY23 revenue $509.3M, consensus $505.05M
4M ago
NVCR
Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M
PremiumThe Fly
Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M
4M ago
NVCR
Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M
PremiumThe Fly
Novocure reports preliminary Q4 revenue $133.8M, consensus $129.3M
4M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >